文献速递眼底病与葡萄膜炎

全民医保下新生血管性年龄相关性黄斑变性患者治疗延迟随访的风险因素与视力结局

DELAYED FOLLOW-UP IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED UNDER UNIVERSAL HEALTH COVERAGE: Risk Factors and Visual Outcomes.
PubMed 文献 · Retina · 2022-01-01

这项回顾性研究纳入加拿大魁北克2个中心2013年1月至2020年12月接受抗血管内皮生长因子注射的新生血管性年龄相关性黄斑变性患者1291例,报告延迟随访(DFU,定义为较计划延迟≥4周)发生率为27.2%,并分析其风险因素及对视力结局的影响。

要点

  • 351例(27.2%)患者发生至少1次延迟随访(DFU)。
  • 高龄、在医院而非诊所治疗、初始视力较差与DFU风险增加相关。
  • DFU与6个月时平均视力下降4.2个字母及视网膜内液、视网膜下液发生率增加相关,恢复注射后未恢复。

核心结论

  • 在全民医疗保健系统下治疗的新生血管性年龄相关性黄斑变性患者中,延迟随访(DFU)率约为27%。
  • 延迟随访导致视力显著下降以及光学相干断层扫描上视网膜内液和视网膜下液增加,尽管恢复注射后中心凹厚度恢复正常,但这些改变未恢复。

研究设计与样本

  • 回顾性研究,纳入加拿大魁北克2个中心2013年1月至2020年12月接受抗血管内皮生长因子注射治疗的新生血管性年龄相关性黄斑变性患者共1291例。
  • 延迟随访(DFU)定义为较计划随访延迟≥4周。

主要发现

  • 351例患者(27.2%)发生至少1次延迟随访(DFU)。
  • 高龄患者(P=0.005)、在医院而非诊所治疗的患者(P<0.001)以及初始视力较差的患者(P=0.024)发生DFU的比值更高。
  • DFU与平均视力下降4.2±13.4个字母(P<0.001)相关,并与6个月时视网膜内液(P=0.001)和视网膜下液(P=0.005)发生率增加相关,尽管已恢复注射。
  • DFU后中心凹厚度增加,但在6个月时恢复至DFU前访视水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/PURPOSE: To report the rate of delayed follow-up visits (DFU), to identify risk factors of DFU, and to assess the impact of DFU on outcomes in neovascular age-related macular degeneration. METHODS: This retrospective study included all patients with neovascular age-related macular degeneration (n = 1,291) treated with antivascular endothelial growth factor injections between January 2013 and December 2020 in 2 centers in Quebec, Canada. A DFU was defined as a delay of ≥4 weeks than scheduled. Visual outcomes, especially ≥15 letters loss, were reported. RESULTS: A total of 351 patients (27.2%) experienced ≥1 DFU. Odds were greater among older patients ( P = 0.005), patients treated at the hospital rather than the clinic ( P < 0.001), and patients with worse initial visual acuity ( P = 0.024). A DFU was associated with a mean visual acuity loss of 4.2 ± 13.4 letters ( P < 0.001) and an increased incidence of intraretinal fluid and subretinal fluid ( P = 0.001, P = 0.005) at 6 months despite resumption of injections. Central foveal thickness increased after DFU but returned to pre-DFU visit at 6 months. CONCLUSION: The DFU rate in patients with neovascular age-related macular degeneration treated under a universal health care system was around 27%. Delayed follow-up visits caused significant decreases in visual acuity and increases in intraretinal fluid and subretinal fluid on optical coherence tomography that did not recover after injections resumption despite normalization of central foveal thickness.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Rozon JP, Hébert M, Laverdière C, et al. DELAYED FOLLOW-UP IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED UNDER UNIVERSAL HEALTH COVERAGE: Risk Factors and Visual Outcomes. Retina. 2022. PMID: 35504012. doi:10.1097/IAE.0000000000003512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。